C WorldWide Group’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

C WorldWide Group’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-400,273	Closed	-$829K	–	144
2015 Q1	$829K	Hold	400,273	–	–	0.01%	95
2014 Q4	$596K	Sell	400,273 -315,307	-44%	-$563K	0.01%	92
2014 Q3	$1.72M	Buy	+715,580	New	+$2.73M	0.03%	80

Other funds holding ALXA

LPA

Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

HHMI

Howard Hughes Medical Institute Chevy Chase, Maryland $445M AUM 42.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

C WorldWide Group's ALXA Position: Q2 2015 in Review

C WorldWide Group sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2015, closing a stake of 400,273 shares — an estimated $829K sold.

C WorldWide Group first reported a position in ALXA in Q3 2014 and held it in 3 quarters. The position peaked at $1.72M in Q3 2014. 22 funds tracked by Wall St. Rank hold ALXA as of Q2 2015.

C WorldWide Group reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
C WorldWide Group sold 400,273 Alexza Pharmaceuticals Inc shares in Q2 2015, an estimated $829K.
C WorldWide Group first reported a position in Alexza Pharmaceuticals Inc in Q3 2014 and held it in 3 quarters.
C WorldWide Group's Alexza Pharmaceuticals Inc position peaked at $1.72M in Q3 2014.
22 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2015.

Based on C WorldWide Group's 13F filing for Q2 2015, filed 21 Jul 2015.